Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

  1. Turkova, A.
  2. White, E.
  3. Mujuru, H.A.
  4. Kekitiinwa, A.R.
  5. Kityo, C.M.
  6. Violari, A.
  7. Lugemwa, A.
  8. Cressey, T.R.
  9. Musoke, P.
  10. Variava, E.
  11. Cotton, M.F.
  12. Archary, M.
  13. Puthanakit, T.
  14. Behuhuma, O.
  15. Kobbe, R.
  16. Welch, S.B.
  17. Bwakura-Dangarembizi, M.
  18. Amuge, P.
  19. Kaudha, E.
  20. Barlow-Mosha, L.
  21. Makumbi, S.
  22. Ramsagar, N.
  23. Ngampiyaskul, C.
  24. Musoro, G.
  25. Atwine, L.
  26. Liberty, A.
  27. Musiime, V.
  28. Bbuye, D.
  29. Ahimbisibwe, G.M.
  30. Chalermpantmetagul, S.
  31. Ali, S.
  32. Sarfati, T.
  33. Wynne, B.
  34. Shakeshaft, C.
  35. Colbers, A.
  36. Klein, N.
  37. Bernays, S.
  38. Saïdi, Y.
  39. Coelho, A.
  40. Grossele, T.
  41. Compagnucci, A.
  42. Giaquinto, C.
  43. Rojo, P.
  44. Ford, D.
  45. Gibb, D.M.
  46. Show all authors +
Journal:
New England Journal of Medicine

ISSN: 1533-4406 0028-4793

Year of publication: 2021

Volume: 385

Issue: 27

Pages: 2531-2543

Type: Article

DOI: 10.1056/NEJMOA2108793 GOOGLE SCHOLAR

Sustainable development goals